Device type · NPJ
Prosthesis, Knee Patellofemorotibial, Partial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NPJ
Orthopedic
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
41
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Knee Patellofemorotibial, Partial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
- Product code
- NPJ
- Device class
- Class II
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3560
- Specialty
- Orthopedic Surgery, Joint Reconstruction
- FDA record
- Classification database entry for NPJ
Latest FDA decisions
K150307 · Decided Mar 10, 2015 · 29 days after receipt
Device type: Prosthesis, Knee Patellofemorotibial, Partial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (NPJ) · Orthopedic Surgery
Reports received
41
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
10
24% of reports
Injury reports
30
73% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 1 | 4 | 0 | 0 |
| Feb 24 | 0 | 6 | 0 | 0 |
| Mar 24 | 0 | 8 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 5 | 0 | 0 |
| Jun 24 | 0 | 2 | 0 | 0 |
| Jul 24 | 0 | 3 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 0 | 4 | 0 | 0 |
| Nov 24 | 0 | 2 | 0 | 0 |
| Dec 24 | 3 | 3 | 0 | 0 |
| Jan 25 | 1 | 2 | 0 | 0 |
| Feb 25 | 1 | 3 | 0 | 0 |
| Mar 25 | 1 | 3 | 0 | 0 |
| Apr 25 | 0 | 6 | 0 | 0 |
| May 25 | 3 | 2 | 0 | 0 |
| Jun 25 | 0 | 4 | 0 | 0 |
| Jul 25 | 0 | 4 | 0 | 0 |
| Aug 25 | 2 | 2 | 0 | 0 |
| Sep 25 | 0 | 3 | 0 | 0 |
| Oct 25 | 0 | 3 | 0 | 0 |
| Nov 25 | 0 | 7 | 0 | 0 |
| Dec 25 | 0 | 2 | 0 | 0 |
| Jan 26 | 0 | 3 | 0 | 0 |
| Feb 26 | 2 | 1 | 0 | 0 |
| Mar 26 | 0 | 6 | 0 | 0 |
| Apr 26 | 0 | 1 | 0 | 0 |
| May 26 | 3 | 3 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 3 | 0 | 0 |
| Sep 26 | 0 | 1 | 0 | 1 |
| Oct 26 | 5 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem12
- Difficult to Insert10
- Fracture6
- Loss of or Failure to Bond5
- Degraded3
- Noise, Audible3
- Loss of Osseointegration2
- Malposition of Device2
- Migration2
- Off-Label Use2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information14
- Pain11
- No Clinical Signs, Symptoms or Conditions7
- Unspecified Infection4
- Inadequate Osseointegration3
- Inflammation3
- Bone Fracture(s)2
- Arthritis1
- Aseptic loosening1
- Fall1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3206-2026 · Started Jul 30, 2026 · Posted by FDA Sep 16, 2026
Reason given: Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in increased wear, leading to hazards such as excessive wear debris, material fragments, fractured device, or...
Cause as FDA categorized it: Process change control
- Restoris MCK Onlay Insert Extractor.Terminated
Z-2051-2018 · Started Jan 19, 2018 · Posted by FDA Jun 1, 2018
Reason given: Possible hinge pin disassociation from the Mako Onlay Insert Extractor.
Cause as FDA categorized it: Under Investigation by firm
Z-1031-2016 · Started Jan 15, 2016
Reason given: Reports where the Mylar/Tyvek pouch for RESTORIS MCK Baseplate in the clamshell packaging configuration exhibited damage, compromising the sterile barrier.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-0142-2016 · Started Aug 31, 2015 · Posted by FDA Oct 21, 2015
Reason given: May contain small amounts of ethylene glycol residue
Cause as FDA categorized it: Process design
Z-0143-2016 · Started Aug 31, 2015 · Posted by FDA Oct 21, 2015
Reason given: May contain small amounts of ethylene glycol residue
Cause as FDA categorized it: Process design
- ConFormis iDUO G2, Right Lateral Catalog Number: M5723INT0600240 (US) M5723INT0600240 (OUS)Terminated
Z-0148-2016 · Started Aug 31, 2015 · Posted by FDA Oct 21, 2015
Reason given: May contain small amounts of ethylene glycol residue
Cause as FDA categorized it: Process design
Z-1132-2014 · Started Jan 9, 2014 · Posted by FDA Mar 4, 2014
Reason given: The product may be mislabeled and could result in the incorrect implant being used.
Cause as FDA categorized it: Error in labeling
Stryker Howmedica Osteonics Corp.
Z-0606-2012 · Started Aug 17, 2011 · Posted by FDA Jan 11, 2012
Reason given: Two National Joint Registries suggest that the EIUS Unicompartmental System is associated with a higher revision rate then the unicompartmental devices.
Cause as FDA categorized it: Other
Showing the 8 newest of 9 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.